Skip to main content

Viv Campbell waits for drug results

Def Leppard guitarist Viv Campbell says he’ll have to wait until next month to discover if his latest treatment for Hodgkin’s lymphoma has been a success.

He’s been battling the disease throughout the recording process of Def Leppard’s self-titled 11th album. And he says he’s hopeful of good news come December.

He tells radio station 100.7 WZXL: “I’m taking this drug called pembrolizumab. I’m part of a phase two clinical trial. I don’t actually know if it’s working yet. I’ll find out in early December.

“My doctors and I are going to sit down and have a look and see if it’s holding the cancer at bay or shrinking the tumours. If it is, I’ll be able to continue this treatment for a couple of years, which will be the best possible outcome. If not, then I’ve got to reconsider my options.

“But I’m hopeful. I started this treatment six months ago, and it’s been fantastic because it meant I was able to continue working as opposed to doing a more traditional treatment which would have meant I would have had to miss the tour.

“And work for me is catharsis. It’s very important to me to be up there on stage doing it, and that’s what keeps me alive.”

The band have also released the first commentary video focusing on the new album, which is out now via a Classic Rock fanpack. View the clip below.

Scott looks after and updates Louder’s online buyer’s guides and also scouts out the best deals for music fans from every corner of the internet. He's spent more than 28 years in newspapers and magazines as an editor, production editor, sub-editor, designer, writer and reviewer. Scott joined our news desk in the summer of 2014, where he wrote extensively about rock, metal, prog and more, before moving to the eCommerce team full-time in 2020. Scott has previous written for publications including IGN, Sunday Mirror, Daily Record and The Herald covering everything from daily news and weekly features, to video games, travel and whisky.